Pinned Tweet
Sick of scrolling through our feed for all the premarket news?
Get all our posts in a free daily email, sign up here openoutcrier.com
Open Outcrier retweeted
$ANT - ANTHROPIC PLANS EARLY SHARE SALES AFTER IPO
Anthropic is preparing an unconventional lock-up structure, allowing some early investors and employees to sell shares before the traditional 180-day restriction expires.
Planned release dates include:
🔸 Day 1: Some shares eligible for sale
🔸 Day 27: Additional shares unlocked
🔸 Day 48: Further shares released
The number of shares eligible for sale has not yet been disclosed.
The key takeaway: Staggered lock-ups could create selling pressure and volatility shortly after Anthropic's IPO.
Source: Anthropic S-1 Filing
$APO (+0.9% pre) Apollo to buy nearly 10% stake in Abu Dhabi-backed alternative asset manager Mubadala Capital
ooc.bz/l/118520
$MSTR (-1.9% pre) Strategy pauses bitcoin purchases, repurchases $204.9M in STRC stock
ooc.bz/l/118517
$VZ (-0.5% pre) Verizon earnings beat by $0.03, revenue fell short of estimates
ooc.bz/l/118515
$MMYT (+2.2% pre) MakeMyTrip stock rises 4% on profit view despite revenue miss
ooc.bz/l/118513
$MED (+5.3% pre) Medifast (NYSE:MED) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
ooc.bz/l/118511
$BOH (+1.0% pre) Bank of Hawaii (NYSE:BOH) Q3 2026 Revenue Miss Offset by Margin Expansion
ooc.bz/l/118509
$ARLP (+3.2% pre) Alliance Resource Partners Q3 profit jumps on record royalty revenues
ooc.bz/l/118507
$XNCR (+33.4% pre) Xencor reports Phase 1 dose data for kidney cancer drug XmAb819
ooc.bz/l/118505
$NBTX (+5.6% pre) NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
ooc.bz/l/118502
$MRNA (-7.3% pre) Moderna’s cancer vaccine is ‘likely’ to get approved. Skeptics question if it will be the best option.
ooc.bz/l/118500
$BNTX (-2.9% pre) BioNTech (BNTX) Reworks Phase 3 Breast Cancer Trial Around New Combination Approach
ooc.bz/l/118499
$AVBP (-2.9% pre) ArriVent reports 44.8% response rate for ADC ARR-217 in CRC patients
ooc.bz/l/118497
$AMRN (+4.3% pre) Amarin’s icosapent ethyl shows survival benefit in cancer trial
ooc.bz/l/118495
$AMGN (+0.5% pre) Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
ooc.bz/l/118493
Open Outcrier retweeted
⏳ JUST 3 DAYS until T4AC Austin!
We're bringing together some incredible people from the trading community, including @TheOneLanceB, @edu_trades, @OpenOutcrier, @traderkylec and @SMBCapital!
Come for the connections. Stay for the fun. Give back while you're at it.
🎟️ traders4acause.org/austin26/
$VAI (+7.9% pre) Valor Energy raises $5M for Ohio computing center acquisition
ooc.bz/l/118490



